Trial intelligence / Profile preview

Effect of Vitamin B6 on Dry Mouth and Blood Pressure in Chronic Kidney Disease

IRCT20250403065196N1Phase 3Completed

Sponsor
Yasouj University of Medical Sciences
Start
May 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of pyridoxine in chronic kidney disease (CKD), xerostomia and hypertension (HTN), sponsored by Yasouj University of Medical Sciences. Primary endpoints: Change in dry mouth severity and Change in blood pressure. Started May 2025; status: completed.

02

Drugs

pyridoxine
03

Conditions

chronic kidney disease (CKD)xerostomiahypertension (HTN)

Beyond the preview

Go deeper on IRCT20250403065196N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20250403065196N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call